nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyclothiazide—SLC12A1—epithelium—breast cancer	0.00437	0.0795	CbGeAlD
Methyclothiazide—SLC12A3—female reproductive system—breast cancer	0.00426	0.0774	CbGeAlD
Methyclothiazide—CA4—nipple—breast cancer	0.00349	0.0635	CbGeAlD
Methyclothiazide—Metolazone—CA9—breast cancer	0.00348	0.202	CrCbGaD
Methyclothiazide—Benzthiazide—CA9—breast cancer	0.00315	0.183	CrCbGaD
Methyclothiazide—Diclofenamide—CA9—breast cancer	0.00313	0.181	CrCbGaD
Methyclothiazide—CA2—nipple—breast cancer	0.0029	0.0527	CbGeAlD
Methyclothiazide—Hydroflumethiazide—CA9—breast cancer	0.00264	0.153	CrCbGaD
Methyclothiazide—Hydrochlorothiazide—CA9—breast cancer	0.00257	0.149	CrCbGaD
Methyclothiazide—CA1—adipose tissue—breast cancer	0.00243	0.0442	CbGeAlD
Methyclothiazide—CA2—embryo—breast cancer	0.00239	0.0435	CbGeAlD
Methyclothiazide—Trichlormethiazide—CA9—breast cancer	0.00229	0.133	CrCbGaD
Methyclothiazide—CA1—female reproductive system—breast cancer	0.00224	0.0407	CbGeAlD
Methyclothiazide—CA1—bone marrow—breast cancer	0.00211	0.0384	CbGeAlD
Methyclothiazide—CA2—epithelium—breast cancer	0.00195	0.0355	CbGeAlD
Methyclothiazide—CA4—pituitary gland—breast cancer	0.00191	0.0347	CbGeAlD
Methyclothiazide—CA4—adipose tissue—breast cancer	0.0019	0.0346	CbGeAlD
Methyclothiazide—CA1—endocrine gland—breast cancer	0.00189	0.0344	CbGeAlD
Methyclothiazide—CA2—skin of body—breast cancer	0.00186	0.0337	CbGeAlD
Methyclothiazide—CA4—female reproductive system—breast cancer	0.00175	0.0318	CbGeAlD
Methyclothiazide—CA4—adrenal gland—breast cancer	0.00171	0.031	CbGeAlD
Methyclothiazide—CA4—bone marrow—breast cancer	0.00165	0.03	CbGeAlD
Methyclothiazide—CA4—female gonad—breast cancer	0.00159	0.0289	CbGeAlD
Methyclothiazide—CA2—pituitary gland—breast cancer	0.00158	0.0288	CbGeAlD
Methyclothiazide—CA2—adipose tissue—breast cancer	0.00158	0.0287	CbGeAlD
Methyclothiazide—CA4—endocrine gland—breast cancer	0.00148	0.0269	CbGeAlD
Methyclothiazide—CA2—female reproductive system—breast cancer	0.00145	0.0264	CbGeAlD
Methyclothiazide—CA2—adrenal gland—breast cancer	0.00141	0.0257	CbGeAlD
Methyclothiazide—CA2—bone marrow—breast cancer	0.00137	0.0249	CbGeAlD
Methyclothiazide—CA2—female gonad—breast cancer	0.00132	0.024	CbGeAlD
Methyclothiazide—CA1—lymph node—breast cancer	0.00131	0.0238	CbGeAlD
Methyclothiazide—CA2—endocrine gland—breast cancer	0.00123	0.0223	CbGeAlD
Methyclothiazide—CA4—lymph node—breast cancer	0.00102	0.0186	CbGeAlD
Methyclothiazide—CA2—lymph node—breast cancer	0.000848	0.0154	CbGeAlD
Methyclothiazide—Anorexia—Mitoxantrone—breast cancer	0.000735	0.00102	CcSEcCtD
Methyclothiazide—Anorexia—Irinotecan—breast cancer	0.000735	0.00102	CcSEcCtD
Methyclothiazide—Diarrhoea—Melphalan—breast cancer	0.000732	0.00101	CcSEcCtD
Methyclothiazide—Nausea—Chlorambucil—breast cancer	0.000729	0.00101	CcSEcCtD
Methyclothiazide—Vision blurred—Paclitaxel—breast cancer	0.000726	0.00101	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Fluorouracil—breast cancer	0.000723	0.001	CcSEcCtD
Methyclothiazide—Dizziness—Tamoxifen—breast cancer	0.000723	0.001	CcSEcCtD
Methyclothiazide—Anorexia—Gemcitabine—breast cancer	0.000716	0.000991	CcSEcCtD
Methyclothiazide—Vomiting—Vinblastine—breast cancer	0.000715	0.00099	CcSEcCtD
Methyclothiazide—Diarrhoea—Goserelin—breast cancer	0.000714	0.000989	CcSEcCtD
Methyclothiazide—Erythema multiforme—Docetaxel—breast cancer	0.000709	0.000982	CcSEcCtD
Methyclothiazide—Urticaria—Thiotepa—breast cancer	0.000709	0.000982	CcSEcCtD
Methyclothiazide—Agitation—Paclitaxel—breast cancer	0.000708	0.00098	CcSEcCtD
Methyclothiazide—Body temperature increased—Thiotepa—breast cancer	0.000706	0.000977	CcSEcCtD
Methyclothiazide—Headache—Vinblastine—breast cancer	0.000705	0.000976	CcSEcCtD
Methyclothiazide—Anorexia—Fluorouracil—breast cancer	0.000704	0.000974	CcSEcCtD
Methyclothiazide—Purpura—Doxorubicin—breast cancer	0.000702	0.000972	CcSEcCtD
Methyclothiazide—Vomiting—Tamoxifen—breast cancer	0.000695	0.000962	CcSEcCtD
Methyclothiazide—Paraesthesia—Irinotecan—breast cancer	0.000692	0.000958	CcSEcCtD
Methyclothiazide—Paraesthesia—Mitoxantrone—breast cancer	0.000692	0.000958	CcSEcCtD
Methyclothiazide—Vertigo—Paclitaxel—breast cancer	0.000692	0.000958	CcSEcCtD
Methyclothiazide—Dizziness—Goserelin—breast cancer	0.00069	0.000956	CcSEcCtD
Methyclothiazide—Leukopenia—Paclitaxel—breast cancer	0.00069	0.000955	CcSEcCtD
Methyclothiazide—Rash—Tamoxifen—breast cancer	0.000689	0.000954	CcSEcCtD
Methyclothiazide—Hypersensitivity—Vinorelbine—breast cancer	0.000689	0.000954	CcSEcCtD
Methyclothiazide—Dermatitis—Tamoxifen—breast cancer	0.000688	0.000953	CcSEcCtD
Methyclothiazide—Erythema multiforme—Capecitabine—breast cancer	0.000687	0.000951	CcSEcCtD
Methyclothiazide—Headache—Tamoxifen—breast cancer	0.000685	0.000948	CcSEcCtD
Methyclothiazide—Vomiting—Melphalan—breast cancer	0.00068	0.000942	CcSEcCtD
Methyclothiazide—Rash—Melphalan—breast cancer	0.000675	0.000934	CcSEcCtD
Methyclothiazide—Paraesthesia—Gemcitabine—breast cancer	0.000674	0.000934	CcSEcCtD
Methyclothiazide—Dermatitis—Melphalan—breast cancer	0.000674	0.000933	CcSEcCtD
Methyclothiazide—Asthenia—Vinorelbine—breast cancer	0.000671	0.000929	CcSEcCtD
Methyclothiazide—Decreased appetite—Mitoxantrone—breast cancer	0.00067	0.000928	CcSEcCtD
Methyclothiazide—Decreased appetite—Irinotecan—breast cancer	0.00067	0.000928	CcSEcCtD
Methyclothiazide—Nausea—Vinblastine—breast cancer	0.000668	0.000925	CcSEcCtD
Methyclothiazide—Orthostatic hypotension—Epirubicin—breast cancer	0.000668	0.000925	CcSEcCtD
Methyclothiazide—Vomiting—Goserelin—breast cancer	0.000664	0.000919	CcSEcCtD
Methyclothiazide—Paraesthesia—Fluorouracil—breast cancer	0.000663	0.000918	CcSEcCtD
Methyclothiazide—Pancreatitis—Methotrexate—breast cancer	0.000662	0.000917	CcSEcCtD
Methyclothiazide—Constipation—Irinotecan—breast cancer	0.000659	0.000913	CcSEcCtD
Methyclothiazide—Constipation—Mitoxantrone—breast cancer	0.000659	0.000913	CcSEcCtD
Methyclothiazide—Rash—Goserelin—breast cancer	0.000658	0.000911	CcSEcCtD
Methyclothiazide—Hypersensitivity—Thiotepa—breast cancer	0.000658	0.000911	CcSEcCtD
Methyclothiazide—Dermatitis—Goserelin—breast cancer	0.000657	0.00091	CcSEcCtD
Methyclothiazide—Headache—Goserelin—breast cancer	0.000654	0.000905	CcSEcCtD
Methyclothiazide—Malnutrition—Docetaxel—breast cancer	0.000653	0.000904	CcSEcCtD
Methyclothiazide—Decreased appetite—Gemcitabine—breast cancer	0.000653	0.000904	CcSEcCtD
Methyclothiazide—Nausea—Tamoxifen—breast cancer	0.000649	0.000899	CcSEcCtD
Methyclothiazide—Constipation—Gemcitabine—breast cancer	0.000642	0.000889	CcSEcCtD
Methyclothiazide—Decreased appetite—Fluorouracil—breast cancer	0.000642	0.000889	CcSEcCtD
Methyclothiazide—Asthenia—Thiotepa—breast cancer	0.00064	0.000887	CcSEcCtD
Methyclothiazide—Diarrhoea—Vinorelbine—breast cancer	0.00064	0.000885	CcSEcCtD
Methyclothiazide—Nausea—Melphalan—breast cancer	0.000636	0.00088	CcSEcCtD
Methyclothiazide—Malnutrition—Capecitabine—breast cancer	0.000632	0.000875	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Paclitaxel—breast cancer	0.000629	0.000871	CcSEcCtD
Methyclothiazide—Muscle spasms—Docetaxel—breast cancer	0.000628	0.000869	CcSEcCtD
Methyclothiazide—Nausea—Goserelin—breast cancer	0.00062	0.000858	CcSEcCtD
Methyclothiazide—Pancreatitis—Epirubicin—breast cancer	0.00062	0.000858	CcSEcCtD
Methyclothiazide—Dizziness—Vinorelbine—breast cancer	0.000618	0.000856	CcSEcCtD
Methyclothiazide—Orthostatic hypotension—Doxorubicin—breast cancer	0.000618	0.000856	CcSEcCtD
Methyclothiazide—Photosensitivity reaction—Methotrexate—breast cancer	0.000616	0.000854	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Paclitaxel—breast cancer	0.000616	0.000852	CcSEcCtD
Methyclothiazide—Urticaria—Mitoxantrone—breast cancer	0.000612	0.000848	CcSEcCtD
Methyclothiazide—Diarrhoea—Thiotepa—breast cancer	0.000611	0.000846	CcSEcCtD
Methyclothiazide—Body temperature increased—Irinotecan—breast cancer	0.000609	0.000844	CcSEcCtD
Methyclothiazide—Body temperature increased—Mitoxantrone—breast cancer	0.000609	0.000844	CcSEcCtD
Methyclothiazide—Muscle spasms—Capecitabine—breast cancer	0.000608	0.000842	CcSEcCtD
Methyclothiazide—Pneumonia—Methotrexate—breast cancer	0.000606	0.000839	CcSEcCtD
Methyclothiazide—Anorexia—Paclitaxel—breast cancer	0.000599	0.00083	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Methotrexate—breast cancer	0.000597	0.000827	CcSEcCtD
Methyclothiazide—Vision blurred—Capecitabine—breast cancer	0.000596	0.000825	CcSEcCtD
Methyclothiazide—Vomiting—Vinorelbine—breast cancer	0.000594	0.000823	CcSEcCtD
Methyclothiazide—Body temperature increased—Gemcitabine—breast cancer	0.000594	0.000822	CcSEcCtD
Methyclothiazide—Dizziness—Thiotepa—breast cancer	0.00059	0.000817	CcSEcCtD
Methyclothiazide—Rash—Vinorelbine—breast cancer	0.000589	0.000816	CcSEcCtD
Methyclothiazide—Dermatitis—Vinorelbine—breast cancer	0.000589	0.000815	CcSEcCtD
Methyclothiazide—Urticaria—Fluorouracil—breast cancer	0.000587	0.000812	CcSEcCtD
Methyclothiazide—Headache—Vinorelbine—breast cancer	0.000586	0.000811	CcSEcCtD
Methyclothiazide—Leukopenia—Docetaxel—breast cancer	0.000584	0.000809	CcSEcCtD
Methyclothiazide—Body temperature increased—Fluorouracil—breast cancer	0.000584	0.000808	CcSEcCtD
Methyclothiazide—Photosensitivity reaction—Epirubicin—breast cancer	0.000577	0.000799	CcSEcCtD
Methyclothiazide—Pancreatitis—Doxorubicin—breast cancer	0.000573	0.000794	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Epirubicin—breast cancer	0.00057	0.000789	CcSEcCtD
Methyclothiazide—Vertigo—Capecitabine—breast cancer	0.000568	0.000786	CcSEcCtD
Methyclothiazide—Hypersensitivity—Mitoxantrone—breast cancer	0.000568	0.000786	CcSEcCtD
Methyclothiazide—Hypersensitivity—Irinotecan—breast cancer	0.000568	0.000786	CcSEcCtD
Methyclothiazide—Vomiting—Thiotepa—breast cancer	0.000568	0.000786	CcSEcCtD
Methyclothiazide—Pneumonia—Epirubicin—breast cancer	0.000567	0.000785	CcSEcCtD
Methyclothiazide—Leukopenia—Capecitabine—breast cancer	0.000566	0.000784	CcSEcCtD
Methyclothiazide—Paraesthesia—Paclitaxel—breast cancer	0.000565	0.000782	CcSEcCtD
Methyclothiazide—Rash—Thiotepa—breast cancer	0.000563	0.000779	CcSEcCtD
Methyclothiazide—Dermatitis—Thiotepa—breast cancer	0.000562	0.000779	CcSEcCtD
Methyclothiazide—Agranulocytosis—Methotrexate—breast cancer	0.000562	0.000778	CcSEcCtD
Methyclothiazide—Headache—Thiotepa—breast cancer	0.000559	0.000774	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Epirubicin—breast cancer	0.000559	0.000774	CcSEcCtD
Methyclothiazide—Nausea—Vinorelbine—breast cancer	0.000555	0.000769	CcSEcCtD
Methyclothiazide—Asthenia—Mitoxantrone—breast cancer	0.000553	0.000766	CcSEcCtD
Methyclothiazide—Asthenia—Irinotecan—breast cancer	0.000553	0.000766	CcSEcCtD
Methyclothiazide—Jaundice—Epirubicin—breast cancer	0.000549	0.000761	CcSEcCtD
Methyclothiazide—Decreased appetite—Paclitaxel—breast cancer	0.000547	0.000757	CcSEcCtD
Methyclothiazide—Hypersensitivity—Fluorouracil—breast cancer	0.000544	0.000753	CcSEcCtD
Methyclothiazide—Asthenia—Gemcitabine—breast cancer	0.000539	0.000746	CcSEcCtD
Methyclothiazide—Constipation—Paclitaxel—breast cancer	0.000538	0.000744	CcSEcCtD
Methyclothiazide—Photosensitivity reaction—Doxorubicin—breast cancer	0.000534	0.000739	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Docetaxel—breast cancer	0.000533	0.000738	CcSEcCtD
Methyclothiazide—Nausea—Thiotepa—breast cancer	0.00053	0.000734	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Doxorubicin—breast cancer	0.000528	0.00073	CcSEcCtD
Methyclothiazide—Diarrhoea—Mitoxantrone—breast cancer	0.000527	0.00073	CcSEcCtD
Methyclothiazide—Diarrhoea—Irinotecan—breast cancer	0.000527	0.00073	CcSEcCtD
Methyclothiazide—Agranulocytosis—Epirubicin—breast cancer	0.000526	0.000728	CcSEcCtD
Methyclothiazide—Pneumonia—Doxorubicin—breast cancer	0.000524	0.000726	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Docetaxel—breast cancer	0.000522	0.000722	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Doxorubicin—breast cancer	0.000517	0.000716	CcSEcCtD
Methyclothiazide—Diarrhoea—Gemcitabine—breast cancer	0.000514	0.000711	CcSEcCtD
Methyclothiazide—Erythema multiforme—Methotrexate—breast cancer	0.000511	0.000708	CcSEcCtD
Methyclothiazide—Dizziness—Irinotecan—breast cancer	0.00051	0.000706	CcSEcCtD
Methyclothiazide—Jaundice—Doxorubicin—breast cancer	0.000508	0.000704	CcSEcCtD
Methyclothiazide—Anorexia—Docetaxel—breast cancer	0.000508	0.000703	CcSEcCtD
Methyclothiazide—Diarrhoea—Fluorouracil—breast cancer	0.000505	0.000699	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Capecitabine—breast cancer	0.000505	0.000699	CcSEcCtD
Methyclothiazide—Urticaria—Paclitaxel—breast cancer	0.000499	0.000692	CcSEcCtD
Methyclothiazide—Body temperature increased—Paclitaxel—breast cancer	0.000497	0.000688	CcSEcCtD
Methyclothiazide—Anorexia—Capecitabine—breast cancer	0.000492	0.000681	CcSEcCtD
Methyclothiazide—Vomiting—Mitoxantrone—breast cancer	0.00049	0.000679	CcSEcCtD
Methyclothiazide—Vomiting—Irinotecan—breast cancer	0.00049	0.000679	CcSEcCtD
Methyclothiazide—Dizziness—Fluorouracil—breast cancer	0.000488	0.000676	CcSEcCtD
Methyclothiazide—Agranulocytosis—Doxorubicin—breast cancer	0.000487	0.000674	CcSEcCtD
Methyclothiazide—Rash—Irinotecan—breast cancer	0.000486	0.000673	CcSEcCtD
Methyclothiazide—Rash—Mitoxantrone—breast cancer	0.000486	0.000673	CcSEcCtD
Methyclothiazide—Dermatitis—Mitoxantrone—breast cancer	0.000486	0.000672	CcSEcCtD
Methyclothiazide—Dermatitis—Irinotecan—breast cancer	0.000486	0.000672	CcSEcCtD
Methyclothiazide—Headache—Irinotecan—breast cancer	0.000483	0.000669	CcSEcCtD
Methyclothiazide—Headache—Mitoxantrone—breast cancer	0.000483	0.000669	CcSEcCtD
Methyclothiazide—Paraesthesia—Docetaxel—breast cancer	0.000479	0.000663	CcSEcCtD
Methyclothiazide—Erythema multiforme—Epirubicin—breast cancer	0.000478	0.000662	CcSEcCtD
Methyclothiazide—Vomiting—Gemcitabine—breast cancer	0.000477	0.000661	CcSEcCtD
Methyclothiazide—Rash—Gemcitabine—breast cancer	0.000473	0.000656	CcSEcCtD
Methyclothiazide—Dermatitis—Gemcitabine—breast cancer	0.000473	0.000655	CcSEcCtD
Methyclothiazide—Malnutrition—Methotrexate—breast cancer	0.000471	0.000652	CcSEcCtD
Methyclothiazide—Headache—Gemcitabine—breast cancer	0.00047	0.000651	CcSEcCtD
Methyclothiazide—Vomiting—Fluorouracil—breast cancer	0.000469	0.00065	CcSEcCtD
Methyclothiazide—Rash—Fluorouracil—breast cancer	0.000466	0.000645	CcSEcCtD
Methyclothiazide—Dermatitis—Fluorouracil—breast cancer	0.000465	0.000644	CcSEcCtD
Methyclothiazide—Paraesthesia—Capecitabine—breast cancer	0.000463	0.000641	CcSEcCtD
Methyclothiazide—Decreased appetite—Docetaxel—breast cancer	0.000463	0.000641	CcSEcCtD
Methyclothiazide—Hypersensitivity—Paclitaxel—breast cancer	0.000463	0.000641	CcSEcCtD
Methyclothiazide—Headache—Fluorouracil—breast cancer	0.000463	0.00064	CcSEcCtD
Methyclothiazide—Nausea—Mitoxantrone—breast cancer	0.000458	0.000634	CcSEcCtD
Methyclothiazide—Nausea—Irinotecan—breast cancer	0.000458	0.000634	CcSEcCtD
Methyclothiazide—Constipation—Docetaxel—breast cancer	0.000456	0.000631	CcSEcCtD
Methyclothiazide—Asthenia—Paclitaxel—breast cancer	0.000451	0.000625	CcSEcCtD
Methyclothiazide—Decreased appetite—Capecitabine—breast cancer	0.000449	0.000621	CcSEcCtD
Methyclothiazide—Nausea—Gemcitabine—breast cancer	0.000446	0.000618	CcSEcCtD
Methyclothiazide—Vision blurred—Methotrexate—breast cancer	0.000444	0.000614	CcSEcCtD
Methyclothiazide—Erythema multiforme—Doxorubicin—breast cancer	0.000443	0.000613	CcSEcCtD
Methyclothiazide—Constipation—Capecitabine—breast cancer	0.000441	0.000611	CcSEcCtD
Methyclothiazide—Malnutrition—Epirubicin—breast cancer	0.00044	0.00061	CcSEcCtD
Methyclothiazide—Nausea—Fluorouracil—breast cancer	0.000439	0.000607	CcSEcCtD
Methyclothiazide—Diarrhoea—Paclitaxel—breast cancer	0.00043	0.000596	CcSEcCtD
Methyclothiazide—Muscle spasms—Epirubicin—breast cancer	0.000423	0.000586	CcSEcCtD
Methyclothiazide—Vertigo—Methotrexate—breast cancer	0.000423	0.000585	CcSEcCtD
Methyclothiazide—Body temperature increased—Docetaxel—breast cancer	0.000421	0.000583	CcSEcCtD
Methyclothiazide—Leukopenia—Methotrexate—breast cancer	0.000421	0.000583	CcSEcCtD
Methyclothiazide—Dizziness—Paclitaxel—breast cancer	0.000416	0.000576	CcSEcCtD
Methyclothiazide—Vision blurred—Epirubicin—breast cancer	0.000415	0.000575	CcSEcCtD
Methyclothiazide—Urticaria—Capecitabine—breast cancer	0.00041	0.000568	CcSEcCtD
Methyclothiazide—Body temperature increased—Capecitabine—breast cancer	0.000408	0.000565	CcSEcCtD
Methyclothiazide—Malnutrition—Doxorubicin—breast cancer	0.000407	0.000564	CcSEcCtD
Methyclothiazide—Agitation—Epirubicin—breast cancer	0.000405	0.00056	CcSEcCtD
Methyclothiazide—Vomiting—Paclitaxel—breast cancer	0.0004	0.000553	CcSEcCtD
Methyclothiazide—Rash—Paclitaxel—breast cancer	0.000396	0.000549	CcSEcCtD
Methyclothiazide—Dermatitis—Paclitaxel—breast cancer	0.000396	0.000548	CcSEcCtD
Methyclothiazide—Vertigo—Epirubicin—breast cancer	0.000396	0.000548	CcSEcCtD
Methyclothiazide—Leukopenia—Epirubicin—breast cancer	0.000394	0.000546	CcSEcCtD
Methyclothiazide—Headache—Paclitaxel—breast cancer	0.000394	0.000545	CcSEcCtD
Methyclothiazide—Hypersensitivity—Docetaxel—breast cancer	0.000393	0.000544	CcSEcCtD
Methyclothiazide—Muscle spasms—Doxorubicin—breast cancer	0.000392	0.000542	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Methotrexate—breast cancer	0.000384	0.000532	CcSEcCtD
Methyclothiazide—Vision blurred—Doxorubicin—breast cancer	0.000384	0.000532	CcSEcCtD
Methyclothiazide—Asthenia—Docetaxel—breast cancer	0.000382	0.000529	CcSEcCtD
Methyclothiazide—Hypersensitivity—Capecitabine—breast cancer	0.00038	0.000526	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Methotrexate—breast cancer	0.000376	0.000521	CcSEcCtD
Methyclothiazide—Agitation—Doxorubicin—breast cancer	0.000374	0.000519	CcSEcCtD
Methyclothiazide—Nausea—Paclitaxel—breast cancer	0.000373	0.000517	CcSEcCtD
Methyclothiazide—Asthenia—Capecitabine—breast cancer	0.00037	0.000513	CcSEcCtD
Methyclothiazide—Vertigo—Doxorubicin—breast cancer	0.000366	0.000507	CcSEcCtD
Methyclothiazide—Anorexia—Methotrexate—breast cancer	0.000366	0.000507	CcSEcCtD
Methyclothiazide—Leukopenia—Doxorubicin—breast cancer	0.000365	0.000505	CcSEcCtD
Methyclothiazide—Diarrhoea—Docetaxel—breast cancer	0.000365	0.000505	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Epirubicin—breast cancer	0.000359	0.000498	CcSEcCtD
Methyclothiazide—Diarrhoea—Capecitabine—breast cancer	0.000353	0.000489	CcSEcCtD
Methyclothiazide—Dizziness—Docetaxel—breast cancer	0.000352	0.000488	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Epirubicin—breast cancer	0.000352	0.000487	CcSEcCtD
Methyclothiazide—Paraesthesia—Methotrexate—breast cancer	0.000345	0.000478	CcSEcCtD
Methyclothiazide—Anorexia—Epirubicin—breast cancer	0.000343	0.000474	CcSEcCtD
Methyclothiazide—Dizziness—Capecitabine—breast cancer	0.000341	0.000472	CcSEcCtD
Methyclothiazide—Vomiting—Docetaxel—breast cancer	0.000339	0.000469	CcSEcCtD
Methyclothiazide—Rash—Docetaxel—breast cancer	0.000336	0.000465	CcSEcCtD
Methyclothiazide—Dermatitis—Docetaxel—breast cancer	0.000336	0.000465	CcSEcCtD
Methyclothiazide—Decreased appetite—Methotrexate—breast cancer	0.000334	0.000462	CcSEcCtD
Methyclothiazide—Headache—Docetaxel—breast cancer	0.000334	0.000462	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Doxorubicin—breast cancer	0.000333	0.00046	CcSEcCtD
Methyclothiazide—Vomiting—Capecitabine—breast cancer	0.000328	0.000454	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Doxorubicin—breast cancer	0.000326	0.000451	CcSEcCtD
Methyclothiazide—Rash—Capecitabine—breast cancer	0.000325	0.00045	CcSEcCtD
Methyclothiazide—Dermatitis—Capecitabine—breast cancer	0.000325	0.00045	CcSEcCtD
Methyclothiazide—Headache—Capecitabine—breast cancer	0.000323	0.000448	CcSEcCtD
Methyclothiazide—Paraesthesia—Epirubicin—breast cancer	0.000323	0.000447	CcSEcCtD
Methyclothiazide—Anorexia—Doxorubicin—breast cancer	0.000317	0.000439	CcSEcCtD
Methyclothiazide—Nausea—Docetaxel—breast cancer	0.000317	0.000438	CcSEcCtD
Methyclothiazide—Decreased appetite—Epirubicin—breast cancer	0.000312	0.000433	CcSEcCtD
Methyclothiazide—CA1—Metabolism—SHMT1—breast cancer	0.000309	0.0015	CbGpPWpGaD
Methyclothiazide—Constipation—Epirubicin—breast cancer	0.000307	0.000426	CcSEcCtD
Methyclothiazide—Nausea—Capecitabine—breast cancer	0.000306	0.000424	CcSEcCtD
Methyclothiazide—Urticaria—Methotrexate—breast cancer	0.000305	0.000422	CcSEcCtD
Methyclothiazide—CA1—C-MYB transcription factor network—HRAS—breast cancer	0.000304	0.00148	CbGpPWpGaD
Methyclothiazide—Body temperature increased—Methotrexate—breast cancer	0.000304	0.00042	CcSEcCtD
Methyclothiazide—CA2—Metabolism—APRT—breast cancer	0.0003	0.00146	CbGpPWpGaD
Methyclothiazide—Paraesthesia—Doxorubicin—breast cancer	0.000299	0.000413	CcSEcCtD
Methyclothiazide—CA1—Metabolism—SLC2A5—breast cancer	0.000297	0.00145	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—SLCO1B1—breast cancer	0.000297	0.00145	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ESRRA—breast cancer	0.000294	0.00143	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ANGPTL4—breast cancer	0.000294	0.00143	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—NCOA1—breast cancer	0.000294	0.00143	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—HMOX1—breast cancer	0.000291	0.00142	CbGpPWpGaD
Methyclothiazide—Decreased appetite—Doxorubicin—breast cancer	0.000289	0.0004	CcSEcCtD
Methyclothiazide—CA1—Metabolism—APRT—breast cancer	0.000287	0.0014	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—PLG—breast cancer	0.000286	0.00139	CbGpPWpGaD
Methyclothiazide—Urticaria—Epirubicin—breast cancer	0.000286	0.000395	CcSEcCtD
Methyclothiazide—Constipation—Doxorubicin—breast cancer	0.000284	0.000394	CcSEcCtD
Methyclothiazide—Body temperature increased—Epirubicin—breast cancer	0.000284	0.000393	CcSEcCtD
Methyclothiazide—Hypersensitivity—Methotrexate—breast cancer	0.000283	0.000392	CcSEcCtD
Methyclothiazide—CA2—Metabolism—ANGPTL4—breast cancer	0.000282	0.00137	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ESRRA—breast cancer	0.000282	0.00137	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—ABCB1—breast cancer	0.000279	0.00136	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—HADHB—breast cancer	0.000278	0.00136	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—GPI—breast cancer	0.000278	0.00136	CbGpPWpGaD
Methyclothiazide—Asthenia—Methotrexate—breast cancer	0.000276	0.000382	CcSEcCtD
Methyclothiazide—CA1—Metabolism—ESRRA—breast cancer	0.00027	0.00131	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ANGPTL4—breast cancer	0.00027	0.00131	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—GPI—breast cancer	0.000267	0.0013	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—HADHB—breast cancer	0.000267	0.0013	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ALDH1A1—breast cancer	0.000266	0.00129	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ALDH7A1—breast cancer	0.000266	0.00129	CbGpPWpGaD
Methyclothiazide—Hypersensitivity—Epirubicin—breast cancer	0.000265	0.000367	CcSEcCtD
Methyclothiazide—Urticaria—Doxorubicin—breast cancer	0.000264	0.000366	CcSEcCtD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—HMOX1—breast cancer	0.000264	0.00129	CbGpPWpGaD
Methyclothiazide—Body temperature increased—Doxorubicin—breast cancer	0.000263	0.000364	CcSEcCtD
Methyclothiazide—Diarrhoea—Methotrexate—breast cancer	0.000263	0.000364	CcSEcCtD
Methyclothiazide—Asthenia—Epirubicin—breast cancer	0.000258	0.000357	CcSEcCtD
Methyclothiazide—CA1—Metabolism—HADHB—breast cancer	0.000256	0.00125	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—GPI—breast cancer	0.000256	0.00125	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ALDH1A1—breast cancer	0.000255	0.00124	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ALDH7A1—breast cancer	0.000255	0.00124	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—UMPS—breast cancer	0.000255	0.00124	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—NME1—breast cancer	0.000255	0.00124	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PHGDH—breast cancer	0.000255	0.00124	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ADSL—breast cancer	0.000255	0.00124	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—FHL2—breast cancer	0.000255	0.00124	CbGpPWpGaD
Methyclothiazide—Dizziness—Methotrexate—breast cancer	0.000254	0.000352	CcSEcCtD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—ABCB1—breast cancer	0.000253	0.00123	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—BRIP1—breast cancer	0.00025	0.00122	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—HPSE—breast cancer	0.00025	0.00122	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—LDHB—breast cancer	0.00025	0.00122	CbGpPWpGaD
Methyclothiazide—Diarrhoea—Epirubicin—breast cancer	0.000246	0.000341	CcSEcCtD
Methyclothiazide—Hypersensitivity—Doxorubicin—breast cancer	0.000245	0.000339	CcSEcCtD
Methyclothiazide—Vomiting—Methotrexate—breast cancer	0.000244	0.000338	CcSEcCtD
Methyclothiazide—CA2—Metabolism—NME1—breast cancer	0.000244	0.00119	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ALDH1A1—breast cancer	0.000244	0.00119	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ALDH7A1—breast cancer	0.000244	0.00119	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—UMPS—breast cancer	0.000244	0.00119	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ADSL—breast cancer	0.000244	0.00119	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PHGDH—breast cancer	0.000244	0.00119	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—FHL2—breast cancer	0.000244	0.00119	CbGpPWpGaD
Methyclothiazide—Rash—Methotrexate—breast cancer	0.000242	0.000335	CcSEcCtD
Methyclothiazide—Dermatitis—Methotrexate—breast cancer	0.000242	0.000335	CcSEcCtD
Methyclothiazide—Headache—Methotrexate—breast cancer	0.000241	0.000333	CcSEcCtD
Methyclothiazide—CA2—Metabolism—BRIP1—breast cancer	0.000239	0.00117	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—LDHB—breast cancer	0.000239	0.00117	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—HPSE—breast cancer	0.000239	0.00117	CbGpPWpGaD
Methyclothiazide—Asthenia—Doxorubicin—breast cancer	0.000239	0.00033	CcSEcCtD
Methyclothiazide—Dizziness—Epirubicin—breast cancer	0.000238	0.000329	CcSEcCtD
Methyclothiazide—CA4—Metabolism—ABCC1—breast cancer	0.000237	0.00115	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—HMMR—breast cancer	0.000237	0.00115	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—GSTA3—breast cancer	0.000237	0.00115	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—UMPS—breast cancer	0.000234	0.00114	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—FHL2—breast cancer	0.000234	0.00114	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PHGDH—breast cancer	0.000234	0.00114	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ADSL—breast cancer	0.000234	0.00114	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—NME1—breast cancer	0.000234	0.00114	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—HPSE—breast cancer	0.00023	0.00112	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—BRIP1—breast cancer	0.00023	0.00112	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—LDHB—breast cancer	0.00023	0.00112	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PPARGC1B—breast cancer	0.000229	0.00112	CbGpPWpGaD
Methyclothiazide—Vomiting—Epirubicin—breast cancer	0.000229	0.000316	CcSEcCtD
Methyclothiazide—Nausea—Methotrexate—breast cancer	0.000228	0.000316	CcSEcCtD
Methyclothiazide—Diarrhoea—Doxorubicin—breast cancer	0.000228	0.000315	CcSEcCtD
Methyclothiazide—CA2—Metabolism—GSTA3—breast cancer	0.000227	0.0011	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—HMMR—breast cancer	0.000227	0.0011	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ABCC1—breast cancer	0.000227	0.0011	CbGpPWpGaD
Methyclothiazide—Rash—Epirubicin—breast cancer	0.000227	0.000314	CcSEcCtD
Methyclothiazide—Dermatitis—Epirubicin—breast cancer	0.000226	0.000313	CcSEcCtD
Methyclothiazide—Headache—Epirubicin—breast cancer	0.000225	0.000312	CcSEcCtD
Methyclothiazide—Dizziness—Doxorubicin—breast cancer	0.00022	0.000305	CcSEcCtD
Methyclothiazide—CA2—Metabolism—PPARGC1B—breast cancer	0.00022	0.00107	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—HMMR—breast cancer	0.000218	0.00106	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—GSTA3—breast cancer	0.000218	0.00106	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ABCC1—breast cancer	0.000218	0.00106	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—GSTA4—breast cancer	0.000217	0.00105	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CA9—breast cancer	0.000217	0.00105	CbGpPWpGaD
Methyclothiazide—Nausea—Epirubicin—breast cancer	0.000213	0.000296	CcSEcCtD
Methyclothiazide—Vomiting—Doxorubicin—breast cancer	0.000211	0.000293	CcSEcCtD
Methyclothiazide—CA4—Metabolism—GPX2—breast cancer	0.000211	0.00103	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—GSTA2—breast cancer	0.000211	0.00103	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PPARGC1B—breast cancer	0.000211	0.00103	CbGpPWpGaD
Methyclothiazide—Rash—Doxorubicin—breast cancer	0.00021	0.00029	CcSEcCtD
Methyclothiazide—Dermatitis—Doxorubicin—breast cancer	0.00021	0.00029	CcSEcCtD
Methyclothiazide—CA4—Metabolism—SULT1A1—breast cancer	0.000208	0.00101	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—GPX4—breast cancer	0.000208	0.00101	CbGpPWpGaD
Methyclothiazide—Headache—Doxorubicin—breast cancer	0.000208	0.000288	CcSEcCtD
Methyclothiazide—CA2—Metabolism—CA9—breast cancer	0.000208	0.00101	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—GSTA4—breast cancer	0.000208	0.00101	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—IDH1—breast cancer	0.000204	0.000991	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—GSTA1—breast cancer	0.000204	0.000991	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—GSTA2—breast cancer	0.000202	0.000985	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—GPX2—breast cancer	0.000202	0.000985	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—NAT2—breast cancer	0.000201	0.00098	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—GPX4—breast cancer	0.0002	0.000973	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—SULT1A1—breast cancer	0.0002	0.000973	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CA9—breast cancer	0.000199	0.000969	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—GSTA4—breast cancer	0.000199	0.000969	CbGpPWpGaD
Methyclothiazide—Nausea—Doxorubicin—breast cancer	0.000198	0.000274	CcSEcCtD
Methyclothiazide—CA2—Metabolism—GSTA1—breast cancer	0.000195	0.00095	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—IDH1—breast cancer	0.000195	0.00095	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—GSTA2—breast cancer	0.000194	0.000944	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—GPX2—breast cancer	0.000194	0.000944	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—NAT2—breast cancer	0.000193	0.000939	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—SULT1A1—breast cancer	0.000192	0.000932	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—GPX4—breast cancer	0.000192	0.000932	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—IDH1—breast cancer	0.000187	0.000911	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—GSTA1—breast cancer	0.000187	0.000911	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—NAT2—breast cancer	0.000185	0.000901	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—MED12—breast cancer	0.000177	0.000859	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—DPYD—breast cancer	0.000177	0.000859	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—ALB—breast cancer	0.000175	0.00085	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ALDOA—breast cancer	0.000174	0.000846	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—MED12—breast cancer	0.000169	0.000824	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—DPYD—breast cancer	0.000169	0.000824	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—NCOA3—breast cancer	0.000169	0.000821	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—SLC2A2—breast cancer	0.000168	0.000815	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ALDOA—breast cancer	0.000167	0.000811	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CPT1A—breast cancer	0.000164	0.000799	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—MTR—breast cancer	0.000164	0.000799	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ABCG2—breast cancer	0.000164	0.000799	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—DPYD—breast cancer	0.000162	0.00079	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—MED12—breast cancer	0.000162	0.00079	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—NCOA3—breast cancer	0.000162	0.000787	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—HPGDS—breast cancer	0.000161	0.000783	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—SLC2A2—breast cancer	0.000161	0.000782	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—HBA1—breast cancer	0.00016	0.000778	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ALDOA—breast cancer	0.00016	0.000777	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—ALB—breast cancer	0.000159	0.000772	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—RAF1—breast cancer	0.000158	0.000769	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CPT1A—breast cancer	0.000157	0.000766	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—MTR—breast cancer	0.000157	0.000766	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ABCG2—breast cancer	0.000157	0.000766	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—GSTT1—breast cancer	0.000156	0.00076	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ACHE—breast cancer	0.000156	0.00076	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—NCOA3—breast cancer	0.000155	0.000755	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—HPGDS—breast cancer	0.000154	0.000751	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—SLC2A2—breast cancer	0.000154	0.000749	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—HBA1—breast cancer	0.000153	0.000746	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CPT1A—breast cancer	0.000151	0.000734	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ABCG2—breast cancer	0.000151	0.000734	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—MTR—breast cancer	0.000151	0.000734	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—GSTT1—breast cancer	0.00015	0.000728	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ACHE—breast cancer	0.00015	0.000728	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—HPGDS—breast cancer	0.000148	0.00072	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CYP17A1—breast cancer	0.000148	0.000719	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—HBA1—breast cancer	0.000147	0.000715	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PTGS1—breast cancer	0.000146	0.000712	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ENO1—breast cancer	0.000146	0.000712	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—GSTT1—breast cancer	0.000143	0.000698	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ACHE—breast cancer	0.000143	0.000698	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CYP2D6—breast cancer	0.000143	0.000698	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—RAF1—breast cancer	0.000143	0.000698	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CYP17A1—breast cancer	0.000142	0.000689	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—NCOA2—breast cancer	0.000141	0.000685	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PTGS1—breast cancer	0.00014	0.000682	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ENO1—breast cancer	0.00014	0.000682	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CYP2D6—breast cancer	0.000138	0.000669	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—FASN—breast cancer	0.000137	0.000665	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—BCHE—breast cancer	0.000136	0.000662	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CYP17A1—breast cancer	0.000136	0.000661	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—NCOA2—breast cancer	0.000135	0.000657	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PTGS1—breast cancer	0.000134	0.000654	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ENO1—breast cancer	0.000134	0.000654	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—SLC5A5—breast cancer	0.000134	0.000654	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CYP2D6—breast cancer	0.000132	0.000642	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—FASN—breast cancer	0.000131	0.000637	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—BCHE—breast cancer	0.00013	0.000634	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—NQO1—breast cancer	0.00013	0.000631	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—SLC2A1—breast cancer	0.00013	0.000631	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—NCOA2—breast cancer	0.000129	0.00063	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—SLC5A5—breast cancer	0.000129	0.000627	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CYP3A4—breast cancer	0.000127	0.000616	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—FASN—breast cancer	0.000126	0.000611	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—BCHE—breast cancer	0.000125	0.000608	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—SLC2A1—breast cancer	0.000124	0.000605	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—NQO1—breast cancer	0.000124	0.000605	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CYP1B1—breast cancer	0.000124	0.000605	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—SLC5A5—breast cancer	0.000123	0.000601	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—HSP90AA1—breast cancer	0.000122	0.000594	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CYP3A4—breast cancer	0.000121	0.00059	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CYP1B1—breast cancer	0.000119	0.00058	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—SLC2A1—breast cancer	0.000119	0.00058	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—NQO1—breast cancer	0.000119	0.00058	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—NCOA1—breast cancer	0.000119	0.000577	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—HSP90AA1—breast cancer	0.000117	0.000569	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—STK11—breast cancer	0.000117	0.000569	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CYP19A1—breast cancer	0.000117	0.000569	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CYP3A4—breast cancer	0.000116	0.000566	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CYP1B1—breast cancer	0.000114	0.000556	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—NCOA1—breast cancer	0.000114	0.000554	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—STK11—breast cancer	0.000112	0.000546	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—HSP90AA1—breast cancer	0.000112	0.000546	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CYP19A1—breast cancer	0.000112	0.000546	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—NCOA1—breast cancer	0.000109	0.000531	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—COMT—breast cancer	0.000109	0.000529	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—GSTP1—breast cancer	0.000108	0.000527	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CYP19A1—breast cancer	0.000107	0.000523	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—STK11—breast cancer	0.000107	0.000523	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—HMOX1—breast cancer	0.000107	0.000519	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ITPR1—breast cancer	0.000106	0.000518	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—COMT—breast cancer	0.000104	0.000507	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—GSTP1—breast cancer	0.000104	0.000505	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ABCB1—breast cancer	0.000102	0.000498	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—HMOX1—breast cancer	0.000102	0.000498	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ITPR1—breast cancer	0.000102	0.000497	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—TYMS—breast cancer	0.000101	0.00049	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—COMT—breast cancer	9.99e-05	0.000486	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—GSTP1—breast cancer	9.95e-05	0.000484	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PLA2G4A—breast cancer	9.94e-05	0.000484	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—NCOR1—breast cancer	9.94e-05	0.000484	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—GSTM1—breast cancer	9.94e-05	0.000484	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ABCB1—breast cancer	9.82e-05	0.000478	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—HMOX1—breast cancer	9.81e-05	0.000477	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ITPR1—breast cancer	9.79e-05	0.000476	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—TYMS—breast cancer	9.65e-05	0.000469	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—NCOR1—breast cancer	9.53e-05	0.000464	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PLA2G4A—breast cancer	9.53e-05	0.000464	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—GSTM1—breast cancer	9.53e-05	0.000464	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—GPX1—breast cancer	9.52e-05	0.000463	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CYP1A1—breast cancer	9.43e-05	0.000459	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ABCB1—breast cancer	9.42e-05	0.000458	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ERCC2—breast cancer	9.35e-05	0.000455	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—TYMS—breast cancer	9.25e-05	0.00045	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—NCOR1—breast cancer	9.14e-05	0.000445	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PLA2G4A—breast cancer	9.14e-05	0.000445	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—GSTM1—breast cancer	9.14e-05	0.000445	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—GPX1—breast cancer	9.13e-05	0.000444	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CYP1A1—breast cancer	9.04e-05	0.00044	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ERCC2—breast cancer	8.96e-05	0.000436	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—MTHFR—breast cancer	8.79e-05	0.000428	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—GPX1—breast cancer	8.75e-05	0.000426	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CYP1A1—breast cancer	8.66e-05	0.000422	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ERCC2—breast cancer	8.59e-05	0.000418	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—MTHFR—breast cancer	8.43e-05	0.00041	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CAV1—breast cancer	8.11e-05	0.000394	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—MTHFR—breast cancer	8.08e-05	0.000393	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CAV1—breast cancer	7.77e-05	0.000378	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CAV1—breast cancer	7.45e-05	0.000363	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PIK3CG—breast cancer	7.38e-05	0.000359	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PIK3CG—breast cancer	7.08e-05	0.000344	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PIK3CG—breast cancer	6.79e-05	0.00033	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PIK3CD—breast cancer	6.49e-05	0.000316	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ALB—breast cancer	6.41e-05	0.000312	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PIK3CD—breast cancer	6.22e-05	0.000303	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ALB—breast cancer	6.14e-05	0.000299	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—NOS3—breast cancer	6.13e-05	0.000298	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PIK3CD—breast cancer	5.97e-05	0.00029	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ALB—breast cancer	5.89e-05	0.000287	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—NOS3—breast cancer	5.88e-05	0.000286	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PIK3CB—breast cancer	5.66e-05	0.000275	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—NOS3—breast cancer	5.63e-05	0.000274	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PTGS2—breast cancer	5.61e-05	0.000273	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PIK3CB—breast cancer	5.42e-05	0.000264	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PTGS2—breast cancer	5.37e-05	0.000262	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PIK3CB—breast cancer	5.2e-05	0.000253	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PTGS2—breast cancer	5.15e-05	0.000251	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PTEN—breast cancer	4.89e-05	0.000238	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PTEN—breast cancer	4.69e-05	0.000228	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PTEN—breast cancer	4.49e-05	0.000219	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PIK3CA—breast cancer	3.45e-05	0.000168	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PIK3CA—breast cancer	3.31e-05	0.000161	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PIK3CA—breast cancer	3.17e-05	0.000154	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—AKT1—breast cancer	2.82e-05	0.000137	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—AKT1—breast cancer	2.7e-05	0.000131	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—AKT1—breast cancer	2.59e-05	0.000126	CbGpPWpGaD
